John Sapp retweeted
The latest video in our partnership with @DGlaucomflecken summarizes the results of the VANISH2 trial, which compared catheter ablation versus antiarrhythmic drug therapy for ventricular tachycardia. View the full article for free: nej.md/DrG16
John Sapp retweeted
So proud of my mentor Dr Bill Stevenson, receiving the prestigious Pioneer in Cardiac Pacing and Electrophysiology!!! #HRS2025 #AblateVT @johnlsapp
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
John Sapp retweeted
Presented at #AHA24:
Among patients with ventricular tachycardia and ischemic cardiomyopathy, catheter ablation as an initial therapy led to a lower risk of adverse outcomes than antiarrhythmic drug therapy. Read the full VANISH2 trial results: nej.md/3Z5ECOD
ALT Kaplan–Meier analysis of the primary end point.
John Sapp retweeted
Dr. Stuart Connolly was a giant in Canadian cardiology. His impact is felt by millions of patients worldwide. A profoundly meaningful life and legacy. He will be sorely missed. @HamHealthSci @machealthsci @SCC_CCS obituaries.thespec.com/obitu…
John Sapp retweeted
Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a defibrillator as compared with those who received a defibrillator alone. Read the full RAFT trial results: nej.md/3vF31OS
ALT The probability of death from any cause (the primary outcome) in each group Original Article Long-Term Resynchronization–Defibrillation Therapy
John Sapp retweeted
1. Today I presented the late breaking results of our clinical trial examining AF progression after catheter ablation.
This was a long-term follow up of the CIRCA-DOSE population, a group of 356 patients randomised to Contact force RF or Cryoballoon PVI
doi.org/10.1161/CIRCULATIONA…
John Sapp retweeted
ICMYI last week at @AHAMeetings! NEW evidence supporting cryoablation reducing the progression of #Afib compared to drug therapy! 75% reduction in the progression to persistent AF with cryoablation! Congratulations @DrJasonAndrade and the EARLY-AF investigators! #EPeeps @NEJM
ALT https://www.nejm.org/doi/full/10.1056/NEJMoa2212540
All Canadian kids should know how to save a life - Sign the Petition! chng.it/xdbQ4Dnt via @CdnChange
John Sapp retweeted
Winners of the Young Investigator Award in the Clinical Investigations category are Dr. Christopher Cheung @ChrisCheungMD (1st place) & Dr. Andrew Lin @DrAndrewLin (2nd place).
#ACC22 #TheFaceOfCardiology
Please consider taking this medical research survey? It's from a research friend at UBC.
We really need to understand the effect of the pandemic on willingness to help when people see someone with a cardiac arrest:
ubc.ca1.qualtrics.com/jfe/fo…
Please share widely. Thanks.
John Sapp retweeted
RAFT AF presented at ACC xitter.cf/accintouch/status/1394… #ACC21 #acc #Domresearchdal @AnthonyTang6 @ACCmediacenter @CHRS_SCR @ACCinTouch @research_dal
RAFT-AF: Rhythm control with catheter ablation and rate control with drugs and/or a pacemaker performed similarly in patients with #AFib and #heartfailure for the primary outcome of time to death or HF progression. bit.ly/33R1UKQ #ACC21
John Sapp retweeted
EARLY-AF is now in print at @nejm
I extend a hearty thank you and congratulations to all 18 of our collaborating sites, committee members, coordinators, and most importantly, patient partners.
@UBCDoM @VCHResearch @msfhr @HeartandStroke @CANet_nce
nejm.org/doi/full/10.1056/NE…
CJC has just published the CHRS position statement on management of VT/VF
2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement on the Management of Ventricular Tachycardia and Fibrillation in Patients With Structural Heart Disease onlinecjc.ca/article/S0828-2…
